| Ident. | Authors (with country if any) | Title |
|---|
| 000020 (2020) |
Laure Elens [Belgique] ; Loralie J. Langman [États-Unis] ; Dennis A. Hesselink ; Stein Bergan [Norvège] ; Dirk Jan A. R. Moes ; Mariadelfina Molinaro [Italie] ; Raman Venkataramanan [États-Unis] ; Florian Lemaitre [France] | Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug–Drug Interactions |
| 000052 (2019-06-12) |
Alain Saraux [France] ; Thomas Barnetche [France] ; Guy Baudens [France] ; Isabelle Idier [France] ; Flore Delaporte [France] ; Pascal Hilliquin [France] | Subcutaneous tocilizumab in monotherapy or in combination with csdmard in patients with moderate to severe rheumatoid arthritis: observational study to describe real-world drug retention rate at 12 months. |
| 000066 (2019) |
Emmanuel Andrès [France] ; Noel Lorenzo Villalba [France] ; Abrar-Ahmad Zulfiqar [France] ; Khalid Serraj [Maroc] ; Rachel Mourot-Cottet [France] ; Jacques-Eric Gottenberg [France] | State of Art of Idiosyncratic Drug-Induced Neutropenia or Agranulocytosis, with a Focus on Biotherapies |
| 000127 (2019) |
Théo Willeman [France] ; Jean-François Jourdil [France] ; Elodie Gautier-Veyret [France] ; Bruno Bonaz [France] ; Françoise Stanke-Labesque [France] | A multiplex liquid chromatography tandem mass spectrometry method for the quantification of seven therapeutic monoclonal antibodies: Application for adalimumab therapeutic drug monitoring in patients with Crohn's disease. |
| 000133 (2018-10-19) |
P. Hilliquin [France] ; T. Barnetche [France] ; G. Baudens [France] ; R. Niarra [France] ; I. Idier [France] ; A. Saraux [France] | Subcutaneous Tocilizumab in Monotherapy or in Combination with DMARD in Patients with Moderate to Severe Active Rheumatoid Arthritis: Observational Study to Describe Real-World Drug Retention Rate at 12 Months, Interim Analysis |
| 000222 (2017) |
Elina Zuelgaray ; Fanny Domont [France] ; Nathan Peiffer-Smadja [France] ; David Saadoun [France] ; Patrice Cacoub [France] | Tocilizumab-Induced Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome in Adult-Onset Still Disease: A Case Report |
| 000233 (2017) |
Elina Zuelgaray [France] ; Fanny Domont [France] ; Nathan Peiffer-Smadja [France] ; David Saadoun [France] ; Patrice Cacoub [France] | Tocilizumab-Induced Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome in Adult-Onset Still Disease. |
| 000242 (2017) |
Louise K. Mercer [Royaume-Uni] ; Anne C. Regierer [Allemagne] ; Xavier Mariette [France] ; William G. Dixon [Royaume-Uni] ; Eva Baecklund [Suède] ; Karin Hellgren [Suède] ; Lene Dreyer [Danemark] ; Merete Lund Hetland [Danemark] ; René Cordtz [Danemark] ; Kimme Hyrich [Royaume-Uni] ; Anja Strangfeld [Allemagne] ; Angela Zink [Allemagne] ; Helena Canhao [Portugal] ; M Victoria Hernandez [Espagne] ; Florence Tubach [France] ; Jacques-Eric Gottenberg [France] ; Jacques Morel [France] ; Jakub Zavada [République tchèque] ; Florenzo Iannone [Italie] ; Johan Askling [Suède] ; Joachim Listing [Allemagne] | Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project |
| 000253 (2017) |
Erwin Dreesen ; Peter Bossuyt [Belgique] ; Denis Mulleman [France] ; Ann Gils ; Dora Pascual-Salcedo [Espagne] | Practical recommendations for the use of therapeutic drug monitoring of biopharmaceuticals in inflammatory diseases |
| 000269 (2017) |
Kahina Amrouche [France] ; Christophe Jamin [France] | Influence of drug molecules on regulatory B cells. |
| 000278 (2017) |
Amélie Moreau [France] ; Marc Le Vée [France] ; Elodie Jouan [France] ; Claire Denizot [France] ; Yannick Parmentier [France] ; Olivier Fardel [France] | Effect of Gevokizumab on Interleukin-1β-Mediated Cytochrome P450 3A4 and Drug Transporter Repression in Cultured Human Hepatocytes. |
| 000281 (2017) |
Sara Murias [France] ; Lorena Magallares ; Fatima Albizuri ; Dora Pascual-Salcedo ; Erwin Dreesen ; Denis Mulleman | Current Practices for Therapeutic Drug Monitoring of Biopharmaceuticals in Pediatrics. |
| 000290 (2017) |
Hassan Izzedine [France] ; Mark A. Perazella [États-Unis] | Anticancer Drug-Induced Acute Kidney Injury |
| 000307 (2016) |
B. Clarivet [France] ; P. Robin [France] ; Y M Pers [France] ; R. Ferreira [France] ; J. Lebrun [France] ; C. Jorgensen [France] ; D. Hillaire-Buys [France] ; V. Brés [France] ; J L Faillie [France] | Tocilizumab and mesenteric arterial thrombosis: drug-drug interaction with anticoagulants metabolized by CYP 450 and/or by P-glycoprotein. |
| 000452 (2014) |
Paul Emery [Royaume-Uni] ; Gerd R. Burmester [Allemagne] ; Vivian P. Bykerk [États-Unis] ; Bernard G. Combe [France] ; Daniel E. Furst [États-Unis] ; Emilie Barré [Belgique] ; Chetan S. Karyekar [États-Unis] ; Dennis A. Wong [États-Unis] ; Tom W J. Huizinga [Pays-Bas] | Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period |
| 000494 (2013) |
A. Woerner [Suisse, France] ; F. Uettwiller [France] ; I. Melki [France] ; B. Bader-Meunier [France] ; R. Mouy [France] ; C. Wouters [France] ; P. Quartier [France] | PReS-FINAL-2133: Drug survival and switching of biological agents in systemic juvenile idiopathic arthritis |
| 000499 (2013) |
Yukinori Okada [États-Unis] ; Di Wu [États-Unis, Australie] ; Gosia Trynka [États-Unis] ; Towfique Raj [États-Unis] ; Chikashi Terao [Japon] ; Katsunori Ikari [Japon] ; Yuta Kochi [Japon] ; Koichiro Ohmura [Japon] ; Akari Suzuki [Japon] ; Shinji Yoshida [Japon] ; Robert R. Graham [États-Unis] ; Arun Manoharan [États-Unis] ; Ward Ortmann [États-Unis] ; Tushar Bhangale [États-Unis] ; Joshua C. Denny [États-Unis] ; Robert J. Carroll [États-Unis] ; Anne E. Eyler [États-Unis] ; Jeffrey D. Greenberg [États-Unis] ; Joel M. Kremer [États-Unis] ; Dimitrios A. Pappas [États-Unis] ; Lei Jiang [République populaire de Chine] ; Jian Yin [République populaire de Chine] ; Lingying Ye [République populaire de Chine] ; Ding-Feng Su [République populaire de Chine] ; Jian Yang [Australie] ; Gang Xie [Canada] ; Ed Keystone [Canada] ; Harm-Jan Westra [Pays-Bas] ; T Nu Esko [Estonie, États-Unis] ; Andres Metspalu [Estonie] ; Xuezhong Zhou [République populaire de Chine] ; Namrata Gupta [États-Unis] ; Daniel Mirel [États-Unis] ; Eli A. Stahl [États-Unis] ; Dorothée Diogo [États-Unis] ; Jing Cui [États-Unis] ; Katherine Liao [États-Unis] ; Michael H. Guo [États-Unis] ; Keiko Myouzen [Japon] ; Takahisa Kawaguchi [Japon] ; Marieke J. H. Coenen [Pays-Bas] ; Piet L. C. M. Van Riel [Pays-Bas] ; Mart A. F. J. Van De Laar [Pays-Bas] ; Henk-Jan Guchelaar [Pays-Bas] ; Tom W. J. Huizinga [Pays-Bas] ; Philippe Dieudé [France] ; Xavier Mariette [France] ; S. Louis Bridges [États-Unis] ; Alexandra Zhernakova [Pays-Bas] ; Rene E. M. Toes [Pays-Bas] ; Paul P. Tak [Pays-Bas, Royaume-Uni] ; Corinne Miceli-Richard [France] ; So-Young Bang [Corée du Sud] ; Hye-Soon Lee [Corée du Sud] ; Javier Martin [Espagne] ; Miguel A. Gonzalez-Gay [Espagne] ; Luis Rodriguez-Rodriguez [Espagne] ; Solbritt Rantap Dahlqvist [Suède] ; Lisbeth Rlestig [Suède] ; Hyon K. Choi [États-Unis] ; Yoichiro Kamatani [France] ; Pilar Galan [France] ; Mark Lathrop [Canada] ; Steve Eyre [Royaume-Uni] ; John Bowes [Royaume-Uni] ; Anne Barton [Royaume-Uni] ; Niek De Vries [Pays-Bas] ; Larry W. Moreland [États-Unis] ; Lindsey A. Criswell [États-Unis] ; Elizabeth W. Karlson [États-Unis] ; Atsuo Taniguchi [Japon] ; Ryo Yamada [Japon] ; Michiaki Kubo [Japon] ; Jun S. Liu [États-Unis] ; Sang-Cheol Bae [Corée du Sud] ; Jane Worthington [Royaume-Uni] ; Leonid Padyukov [Suède] ; Lars Klareskog [Suède] ; Peter K. Gregersen [États-Unis] ; Soumya Raychaudhuri [États-Unis, Royaume-Uni] ; Barbara E. Stranger [États-Unis] ; Philip L. De Jager [États-Unis] ; Lude Franke [Pays-Bas] ; Peter M. Visscher [Australie] ; Matthew A. Brown [Australie] ; Hisashi Yamanaka [Japon] ; Tsuneyo Mimori [Japon] ; Atsushi Takahashi [Japon] ; Huji Xu [République populaire de Chine] ; Timothy W. Behrens [États-Unis] ; Katherine A. Siminovitch [Canada] ; Shigeki Momohara [Japon] ; Fumihiko Matsuda [Japon] ; Kazuhiko Yamamoto [Japon] ; Robert M. Plenge [États-Unis] | Genetics of rheumatoid arthritis contributes to biology and drug discovery |
| 000655 (2011) |
Johanna M. W. Hazes [Pays-Bas] ; Pierre G. Coulie [Belgique] ; Vincent Geenen [Belgique] ; Séverine Vermeire [Belgique] ; Franck Carbonnel [France] ; Edouard Louis [Belgique] ; Pierre Masson [Belgique] ; Filip De Keyser [Belgique] | Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiological considerations for drug use |
| 000702 (2010) |
B. Hansel [France] ; E. Bruckert | [Lipid profile and cardiovascular risk in patients with rheumatoid arthritis: Effect of the disease and of drug therapy]. |
